474 related articles for article (PubMed ID: 11739009)
21. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
22. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
[TBL] [Abstract][Full Text] [Related]
23. [Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor].
Zhang Y; Xiang Y; Ren T; Wan XR; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):83-6. PubMed ID: 15840284
[TBL] [Abstract][Full Text] [Related]
24. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
25. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
26. Improved monitoring of gestational trophoblastic neoplasia using a highly sensitive assay for urinary human chorionic gonadotropin.
Wehmann RE; Ayala AR; Birken S; Canfield RE; Nisula BC
Am J Obstet Gynecol; 1981 Aug; 140(7):753-7. PubMed ID: 6266253
[TBL] [Abstract][Full Text] [Related]
27. Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use.
Vartiainen J; Alfthan H; Lehtovirta P; Stenman UH
Contraception; 1998 Apr; 57(4):257-60. PubMed ID: 9649918
[TBL] [Abstract][Full Text] [Related]
28. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
29. A radioimmunoassay for pregnancy associated protein, beta 1SP1: levels in pregnancy, trophoblastic and neoplastic disease.
Elvers LH; Hiemstra G; Lequin RM
Horm Res; 1980; 12(5):245-52. PubMed ID: 6249709
[TBL] [Abstract][Full Text] [Related]
30. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
[TBL] [Abstract][Full Text] [Related]
31. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
32. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and management of gestational trophoblastic disease.
Lewis JL
Cancer; 1993 Feb; 71(4 Suppl):1639-47. PubMed ID: 8381709
[TBL] [Abstract][Full Text] [Related]
34. Partial hydatidiform mole with subsequent trophoblastic tumor; a case report.
Vejerslev LO; Larsen G; Jacobsen M
Eur J Obstet Gynecol Reprod Biol; 1991 Jun; 40(1):73-7. PubMed ID: 1649776
[TBL] [Abstract][Full Text] [Related]
35. Molecular heterogeneity of human chorionic gonadotropin in serum and urine from patients with trophoblastic tumors.
Hoermann R; Spoettl G; Grossmann M; Saller B; Mann K
Clin Investig; 1993 Nov; 71(11):953-60. PubMed ID: 8312691
[TBL] [Abstract][Full Text] [Related]
36. Criteria toward the definition of nonmetastatic gestational trophoblastic disease after hydatidiform mole.
Kohorn EI
Am J Obstet Gynecol; 1982 Feb; 142(4):416-9. PubMed ID: 6277194
[TBL] [Abstract][Full Text] [Related]
37. [Binding of human chorionic gonadotropin with insufficient terminal sugar to peanut agglutinin].
Utsunomiya T; Nishimura R; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):555-61. PubMed ID: 2985718
[TBL] [Abstract][Full Text] [Related]
38. Post-operative follow-up study of trophoblastic tumors using radioimmunoassay for HCG and LH.
Chen T
Acta Obstet Gynaecol Jpn; 1971 Jan; 18(1):13-8. PubMed ID: 4326707
[No Abstract] [Full Text] [Related]
39. New discoveries on the biology and detection of human chorionic gonadotropin.
Cole LA
Reprod Biol Endocrinol; 2009 Jan; 7():8. PubMed ID: 19171054
[TBL] [Abstract][Full Text] [Related]
40. Molecular heterogeneity of hCG β - related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-S32. PubMed ID: 29645231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
